Rapporto annuale 2007 - Istituto di Ricerche Farmacologiche Mario ...

IRFMN
Conferenza: International Conference on Vascular Targeted Therapies in Oncology. “VEGF
released by ovarian cancer cells stimulates organ specific MMP9 expression and invasion”.
Mandelieu (Francia), 4-6 Ottobre 2007.
Conferenza: International Conference on Vascular Targeted Therapies in Oncology. “Molecular
characterization of tumor endothelium and identification of novel markes”. Mandelieu
(Francia), 4-6 Ottobre 2007.
Conferenza: International Conference on Vascular Targeted Therapies in Oncology. “Binding of
thrombospondin-1 type III repeats to fibroblast grown factor-2 as an exploitable mechanism of
angiogenesis inhibition”. Mandelieu (Francia), 4-6 Ottobre 2007.
Conferenza: International Conference on Vascular Targeted Therapies in Oncology. “New
tubulin-binding imidazole derivatives as vascular distrupting agents”. Mandelieu (Francia), 4-6
Ottobre 2007.
Conferenza: International Conference on Vascular Targeted Therapies in Oncology. “Molecular
profile of stroma derived from human ovarian carcinoma xenograft tumors equipped of different
angiogenic phenotypes”. Mandelieu (Francia), 4-6 Ottobre 2007.
Congresso: IX Congresso Nazionale di Oncologia Medica (AIOM). “Endpoints Farmacologici
nello sviluppo e nell’applicazione clinica degli agenti antiangiogenici”. Palermo (Italia),12-15
Ottobre 2007.
Conferenza: AACR/NCI/EORTC International Conference Molecular Targets and Cancer
Therapeutics: Discovery, Biology and Clinical Applications. “Influence of VEGF production on
paclitaxel response in a model of ovarian carcinoma xenograft”. S. Francisco (USA), 22-26
Ottobre 2007.
XV Cochrane Colloquium, Presentation: PartecipaSalute experience, San Paolo (Brasile) 23
ottobre 2007.
Conferenza: 4th International Conference on Thrombosis and Hemostasis Issues in Cancer.
“Protease-activated receptor-1 (PAR-1) expression correlates with a malignant phenotype in
human melanoma”. Bergamo, 26-28 Ottobre 2007.
Gynecologic Cancer Intergroup (GCIG), Charité Ruine, Campus Charité Mitte. Berlino, 28
Ottobre, 2007
VISEAR II, Vienna Initiative to Save European Academic Research II. Vienna, 12 Novembre
2007
Congresso: 24° Congresso della Società Italiana di Chemioterapia. “Pharmacological endpoints
in the development of angiogenesis inhibitors”. Verona 25-28 Novembre 2007.
Meeting: 49th Annual Meeting of the Italian Cancer Society (SIC) “Modulation of endothelial
cell gene expression by angiogenic factors”. Pordenone, 26-29 Novembre 2007.
Meeting: 49th Annual Meeting of the Italian Cancer Society (SIC) “Modulation of tubulin
acetylation affects the sensitive of endothelial cells to the antimotility effects of paclitaxel”.
Pordenone, 26-29 Novembre 2007.
25
RAPPORTO ATTIVITA’ 2007